To ensure consistency and quality of treatment, Libmeldy will be available via qualified treatment centres with adequate experience in haematopoietic stem cell transplantation and the management of leukodystrophies. (see above)
The qualified treatment centre has the required infrastructure, procedures and accreditations in place, which are:
- Appropriate for autologous donations from paediatric patients.
- For the collection of haematopoietic stem and progenitor cells via apheresis to collect mobilised peripheral blood or via bone marrow harvest.